Safety Study of Dantrolene to Treat Cerebral Vasospasm After Subarachnoid Hemorrhage

NCT00964548 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Cerebral Vasospasm After Subarachnoid Hemorrhage

Interventions

DRUG: Dantrolene
DRUG: Dantrolene

Sponsor

University of Massachusetts, Worcester

Collaborators

[object Object]